Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
L04AA26
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
||
|
NDF-RT |
N0000182637
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
||
|
FDA ORPHAN DRUG |
921522
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
||
|
WHO-VATC |
QL04AA26
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
BENLYSTA (AUTHORIZED LUPUS ERYTHEMSTOSUS, SYSTEMIC)
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4949
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
OO-56
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
BELIMUMAB
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
6887
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
73B0K5S26A
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
73B0K5S26A
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
N0000182156
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | Decreased B Lymphocyte Activation [PE] | ||
|
CHEMBL1789843
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
356547-88-1
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
100000090056
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
1092437
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | RxNorm | ||
|
N0000182636
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | B Lymphocyte Stimulator-directed Antibody Interactions [MoA] | ||
|
SUB25607
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
m2294
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | Merck Index | ||
|
8381
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
DB08879
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
C91385
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY | |||
|
Belimumab
Created by
admin on Sat Dec 16 16:32:36 UTC 2023 , Edited by admin on Sat Dec 16 16:32:36 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
